nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—Benign neoplasm of skin—Thalidomide—leprosy	0.0927	0.0927	CcSEcCtD
Ibandronate—Circumoral paresthesia—Thalidomide—leprosy	0.0385	0.0385	CcSEcCtD
Ibandronate—Paraesthesia oral—Thalidomide—leprosy	0.0268	0.0268	CcSEcCtD
Ibandronate—Oral candidiasis—Thalidomide—leprosy	0.0198	0.0198	CcSEcCtD
Ibandronate—Hypomagnesaemia—Thalidomide—leprosy	0.0198	0.0198	CcSEcCtD
Ibandronate—Tooth disorder—Thalidomide—leprosy	0.0193	0.0193	CcSEcCtD
Ibandronate—Neuralgia—Thalidomide—leprosy	0.0181	0.0181	CcSEcCtD
Ibandronate—Nasopharyngitis—Dapsone—leprosy	0.0159	0.0159	CcSEcCtD
Ibandronate—Myocardial ischaemia—Thalidomide—leprosy	0.0156	0.0156	CcSEcCtD
Ibandronate—Influenza—Dapsone—leprosy	0.0154	0.0154	CcSEcCtD
Ibandronate—Endocrine disorder—Thalidomide—leprosy	0.0151	0.0151	CcSEcCtD
Ibandronate—Blood disorder—Thalidomide—leprosy	0.015	0.015	CcSEcCtD
Ibandronate—Musculoskeletal stiffness—Thalidomide—leprosy	0.014	0.014	CcSEcCtD
Ibandronate—Arthropathy—Thalidomide—leprosy	0.0138	0.0138	CcSEcCtD
Ibandronate—Hypocalcaemia—Thalidomide—leprosy	0.0137	0.0137	CcSEcCtD
Ibandronate—Hypercholesterolaemia—Thalidomide—leprosy	0.0133	0.0133	CcSEcCtD
Ibandronate—Creatinine increased—Thalidomide—leprosy	0.0132	0.0132	CcSEcCtD
Ibandronate—Bone pain—Thalidomide—leprosy	0.0131	0.0131	CcSEcCtD
Ibandronate—Pharyngitis—Dapsone—leprosy	0.0122	0.0122	CcSEcCtD
Ibandronate—Candida infection—Thalidomide—leprosy	0.012	0.012	CcSEcCtD
Ibandronate—Oesophagitis—Thalidomide—leprosy	0.0115	0.0115	CcSEcCtD
Ibandronate—Pulmonary oedema—Thalidomide—leprosy	0.0112	0.0112	CcSEcCtD
Ibandronate—Hypertonia—Thalidomide—leprosy	0.011	0.011	CcSEcCtD
Ibandronate—Erythema—Dapsone—leprosy	0.0107	0.0107	CcSEcCtD
Ibandronate—Gastroenteritis—Thalidomide—leprosy	0.0103	0.0103	CcSEcCtD
Ibandronate—Deafness—Thalidomide—leprosy	0.0102	0.0102	CcSEcCtD
Ibandronate—Injury—Thalidomide—leprosy	0.00991	0.00991	CcSEcCtD
Ibandronate—Renal failure acute—Thalidomide—leprosy	0.00987	0.00987	CcSEcCtD
Ibandronate—Amnesia—Thalidomide—leprosy	0.0097	0.0097	CcSEcCtD
Ibandronate—Vertigo—Dapsone—leprosy	0.00963	0.00963	CcSEcCtD
Ibandronate—Arthritis—Thalidomide—leprosy	0.00937	0.00937	CcSEcCtD
Ibandronate—Pain in extremity—Thalidomide—leprosy	0.00911	0.00911	CcSEcCtD
Ibandronate—Osteoarthritis—Thalidomide—leprosy	0.00911	0.00911	CcSEcCtD
Ibandronate—Migraine—Thalidomide—leprosy	0.00897	0.00897	CcSEcCtD
Ibandronate—Face oedema—Thalidomide—leprosy	0.00879	0.00879	CcSEcCtD
Ibandronate—Blood creatinine increased—Thalidomide—leprosy	0.00853	0.00853	CcSEcCtD
Ibandronate—Breast disorder—Thalidomide—leprosy	0.00823	0.00823	CcSEcCtD
Ibandronate—Cramp muscle—Thalidomide—leprosy	0.0082	0.0082	CcSEcCtD
Ibandronate—Insomnia—Dapsone—leprosy	0.00791	0.00791	CcSEcCtD
Ibandronate—Influenza—Thalidomide—leprosy	0.00787	0.00787	CcSEcCtD
Ibandronate—Dysphagia—Thalidomide—leprosy	0.00787	0.00787	CcSEcCtD
Ibandronate—Bronchospasm—Thalidomide—leprosy	0.00774	0.00774	CcSEcCtD
Ibandronate—Bronchitis—Thalidomide—leprosy	0.00757	0.00757	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Thalidomide—leprosy	0.00732	0.00732	CcSEcCtD
Ibandronate—Gastrointestinal pain—Dapsone—leprosy	0.00715	0.00715	CcSEcCtD
Ibandronate—Weight decreased—Thalidomide—leprosy	0.00712	0.00712	CcSEcCtD
Ibandronate—Pneumonia—Thalidomide—leprosy	0.00706	0.00706	CcSEcCtD
Ibandronate—Infestation NOS—Thalidomide—leprosy	0.00702	0.00702	CcSEcCtD
Ibandronate—Infestation—Thalidomide—leprosy	0.00702	0.00702	CcSEcCtD
Ibandronate—Depression—Thalidomide—leprosy	0.007	0.007	CcSEcCtD
Ibandronate—Abdominal pain—Dapsone—leprosy	0.00691	0.00691	CcSEcCtD
Ibandronate—Body temperature increased—Dapsone—leprosy	0.00691	0.00691	CcSEcCtD
Ibandronate—Renal failure—Thalidomide—leprosy	0.0069	0.0069	CcSEcCtD
Ibandronate—Stomatitis—Thalidomide—leprosy	0.00684	0.00684	CcSEcCtD
Ibandronate—Sweating—Thalidomide—leprosy	0.00673	0.00673	CcSEcCtD
Ibandronate—Pharyngitis—Thalidomide—leprosy	0.00625	0.00625	CcSEcCtD
Ibandronate—Urinary tract disorder—Thalidomide—leprosy	0.00622	0.00622	CcSEcCtD
Ibandronate—Oedema peripheral—Thalidomide—leprosy	0.00621	0.00621	CcSEcCtD
Ibandronate—Urethral disorder—Thalidomide—leprosy	0.00618	0.00618	CcSEcCtD
Ibandronate—Eye disorder—Thalidomide—leprosy	0.00589	0.00589	CcSEcCtD
Ibandronate—Cardiac disorder—Thalidomide—leprosy	0.00585	0.00585	CcSEcCtD
Ibandronate—Angiopathy—Thalidomide—leprosy	0.00572	0.00572	CcSEcCtD
Ibandronate—Immune system disorder—Thalidomide—leprosy	0.00569	0.00569	CcSEcCtD
Ibandronate—Mediastinal disorder—Thalidomide—leprosy	0.00568	0.00568	CcSEcCtD
Ibandronate—Chills—Thalidomide—leprosy	0.00565	0.00565	CcSEcCtD
Ibandronate—Alopecia—Thalidomide—leprosy	0.00557	0.00557	CcSEcCtD
Ibandronate—Vomiting—Dapsone—leprosy	0.00556	0.00556	CcSEcCtD
Ibandronate—Mental disorder—Thalidomide—leprosy	0.00552	0.00552	CcSEcCtD
Ibandronate—Malnutrition—Thalidomide—leprosy	0.00549	0.00549	CcSEcCtD
Ibandronate—Headache—Dapsone—leprosy	0.00548	0.00548	CcSEcCtD
Ibandronate—Flatulence—Thalidomide—leprosy	0.00541	0.00541	CcSEcCtD
Ibandronate—Dysgeusia—Thalidomide—leprosy	0.00537	0.00537	CcSEcCtD
Ibandronate—Back pain—Thalidomide—leprosy	0.00531	0.00531	CcSEcCtD
Ibandronate—Muscle spasms—Thalidomide—leprosy	0.00527	0.00527	CcSEcCtD
Ibandronate—Nausea—Dapsone—leprosy	0.0052	0.0052	CcSEcCtD
Ibandronate—Ill-defined disorder—Thalidomide—leprosy	0.00509	0.00509	CcSEcCtD
Ibandronate—Anaemia—Thalidomide—leprosy	0.00507	0.00507	CcSEcCtD
Ibandronate—Angioedema—Thalidomide—leprosy	0.00501	0.00501	CcSEcCtD
Ibandronate—Malaise—Thalidomide—leprosy	0.00495	0.00495	CcSEcCtD
Ibandronate—Vertigo—Thalidomide—leprosy	0.00493	0.00493	CcSEcCtD
Ibandronate—Palpitations—Thalidomide—leprosy	0.00485	0.00485	CcSEcCtD
Ibandronate—Hypertension—Thalidomide—leprosy	0.00474	0.00474	CcSEcCtD
Ibandronate—Myalgia—Thalidomide—leprosy	0.00467	0.00467	CcSEcCtD
Ibandronate—Arthralgia—Thalidomide—leprosy	0.00467	0.00467	CcSEcCtD
Ibandronate—Chest pain—Thalidomide—leprosy	0.00467	0.00467	CcSEcCtD
Ibandronate—Anxiety—Thalidomide—leprosy	0.00465	0.00465	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00464	0.00464	CcSEcCtD
Ibandronate—Discomfort—Thalidomide—leprosy	0.00461	0.00461	CcSEcCtD
Ibandronate—Dry mouth—Thalidomide—leprosy	0.00457	0.00457	CcSEcCtD
Ibandronate—Infection—Thalidomide—leprosy	0.00445	0.00445	CcSEcCtD
Ibandronate—Shock—Thalidomide—leprosy	0.00441	0.00441	CcSEcCtD
Ibandronate—Nervous system disorder—Thalidomide—leprosy	0.00439	0.00439	CcSEcCtD
Ibandronate—Skin disorder—Thalidomide—leprosy	0.00435	0.00435	CcSEcCtD
Ibandronate—Hyperhidrosis—Thalidomide—leprosy	0.00433	0.00433	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Thalidomide—leprosy	0.00408	0.00408	CcSEcCtD
Ibandronate—Insomnia—Thalidomide—leprosy	0.00405	0.00405	CcSEcCtD
Ibandronate—Paraesthesia—Thalidomide—leprosy	0.00402	0.00402	CcSEcCtD
Ibandronate—Dyspepsia—Thalidomide—leprosy	0.00394	0.00394	CcSEcCtD
Ibandronate—Decreased appetite—Thalidomide—leprosy	0.00389	0.00389	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Thalidomide—leprosy	0.00387	0.00387	CcSEcCtD
Ibandronate—Fatigue—Thalidomide—leprosy	0.00386	0.00386	CcSEcCtD
Ibandronate—Constipation—Thalidomide—leprosy	0.00383	0.00383	CcSEcCtD
Ibandronate—Pain—Thalidomide—leprosy	0.00383	0.00383	CcSEcCtD
Ibandronate—Feeling abnormal—Thalidomide—leprosy	0.00369	0.00369	CcSEcCtD
Ibandronate—Gastrointestinal pain—Thalidomide—leprosy	0.00366	0.00366	CcSEcCtD
Ibandronate—Urticaria—Thalidomide—leprosy	0.00356	0.00356	CcSEcCtD
Ibandronate—Body temperature increased—Thalidomide—leprosy	0.00354	0.00354	CcSEcCtD
Ibandronate—Abdominal pain—Thalidomide—leprosy	0.00354	0.00354	CcSEcCtD
Ibandronate—Hypersensitivity—Thalidomide—leprosy	0.0033	0.0033	CcSEcCtD
Ibandronate—Asthenia—Thalidomide—leprosy	0.00321	0.00321	CcSEcCtD
Ibandronate—Pruritus—Thalidomide—leprosy	0.00317	0.00317	CcSEcCtD
Ibandronate—Diarrhoea—Thalidomide—leprosy	0.00306	0.00306	CcSEcCtD
Ibandronate—Dizziness—Thalidomide—leprosy	0.00296	0.00296	CcSEcCtD
Ibandronate—Vomiting—Thalidomide—leprosy	0.00285	0.00285	CcSEcCtD
Ibandronate—Rash—Thalidomide—leprosy	0.00282	0.00282	CcSEcCtD
Ibandronate—Dermatitis—Thalidomide—leprosy	0.00282	0.00282	CcSEcCtD
Ibandronate—Headache—Thalidomide—leprosy	0.00281	0.00281	CcSEcCtD
Ibandronate—Nausea—Thalidomide—leprosy	0.00266	0.00266	CcSEcCtD
